Cardiolux SRL
Cardiolux reported total assets of 729,555 € at the end of the 2025 financial year (annual accounts filed with the NBB on 08 Jul 2026).
The score of Cardiolux shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +208 % Total assets +194 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Cardiolux's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 175,927 € | ||||
| Equity | 701,039 € | ||||
| Cash | 167,942 € | ||||
| EBITDA | 252,596 € | ||||
| Total assets | 729,555 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 08 Jul 2026
- Year ended 31 Dec 2024filed on 25 May 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 19 Jun 2023
- Year ended 31 Dec 2021filed on 10 Jun 2022
Cardiolux's financial analysis
- Solvency96.1%sector median: 67.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Cardiolux
Cardiolux's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0871.621.610
- VAT number
- BE0871621610
- Peppol
- Registered · 0208:0871621610 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 02 Feb 2005
- Registered office
- 1180 Uccle
- Latest accounts
- 2025 · filed on 08 Jul 2026
- Activity
- Medical specialists activities (NACE 86220)
Cardiolux (SRL) has been based in Uccle since 2005, active in: medical specialists activities. For 2025, it reports a net profit of 175,927 € and equity of 701,039 €; its revenue is not published. Its solvency stands at 96.1%, above the median of its sector (67.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Cardiolux
Companies in the same business, of comparable size and area, outside its group.
- Grondt Moorslede · balance sheet 729,585 €
- La FEE du LAC Rixensart · balance sheet 729,585 €
- Orthomas Quévy · balance sheet 729,636 €
- Cabinet Médical Nathalie BORBOUSE Mons · balance sheet 729,472 €
- Sicle Pepinster · balance sheet 728,904 €
- Docteur Nathalie Spinogatti Schaerbeek · balance sheet 730,318 €
- Apotheek Mevrouw Mortelmans-Lantsoght Wholesale of pharmaceutical and medical goods Heist-op-den-Berg · balance sheet 729,560 €
Frequently asked questions about Cardiolux
What is the revenue of Cardiolux?
Cardiolux files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Cardiolux?
In Belgium, the VAT number is the company number prefixed with BE: BE0871621610 for Cardiolux, if the company is VAT-registered. Its company number (CBE) is 0871.621.610.
Where is the registered office of Cardiolux?
According to the CBE register, the registered office of Cardiolux is in 1180 Uccle.
What is the equity of Cardiolux?
At the close of the 2025 financial year, the equity of Cardiolux amounts to 701,039 €, a solvency of 96.1% of total assets.
Who manages Cardiolux?
The register lists 2 active mandates at Cardiolux. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Cardiolux
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →